 |
185 Diseases |  |
81 Trials |
|
81 Trials |  |
6476 News |  |
| «12...70717273747576777879808182» |
- levetiracetam / Generic mfg.
New P2 trial: Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia (clinicaltrials.gov) - Jul 24, 2014
P2, N=7, Recruiting, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
- lacosamide / Generic mfg.
Enrollment closed, Trial primary completion date, Monotherapy: Add on Lacosamide Versus High Dose Monotherapy (clinicaltrials.gov) - Jul 23, 2014
P3, N=20, Active, not recruiting, Sponsor: Brigham and Women's Hospital
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2013 --> Dec 2014
- levetiracetam / Generic mfg.
Trial primary completion date: A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM (clinicaltrials.gov) - Jul 12, 2014
P2, N=0, Recruiting, Sponsor: University of Rochester
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2013 --> Dec 2014 Trial primary completion date: Aug 2014 --> Jun 2015
- ||||| levetiracetam / Generic mfg.
Enrollment change: A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures) (clinicaltrials.gov) - Jul 1, 2014
P3, N=361, Completed, Sponsor: UCB Japan Co. Ltd.
Trial primary completion date: Aug 2014 --> Jun 2015 N=276 --> 361
- ||||||| levetiracetam / Generic mfg.
Trial completion, Enrollment change: A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures) (clinicaltrials.gov) - Jul 1, 2014
P3, N=361, Completed, Sponsor: UCB Japan Co. Ltd.
N=276 --> 361 Active, not recruiting --> Completed | N=276 --> 361
- | clonazepam / Generic mfg., levetiracetam / Generic mfg.
Trial completion: SAMU-KEPPRA: Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus (clinicaltrials.gov) - Jun 24, 2014
P3, N=203, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed | N=276 --> 361 Active, not recruiting --> Completed
- levetiracetam / Generic mfg.
Trial primary completion date: LEV-AD: Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability (clinicaltrials.gov) - Jun 13, 2014
P2, N=36, Recruiting, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Trial primary completion date: Feb 2016 --> Jun 2016
- levetiracetam / Generic mfg.
Trial initiation date: LEV-AD: Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability (clinicaltrials.gov) - Jun 13, 2014
P2, N=36, Recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Feb 2016 --> Jun 2016 Initiation date: Feb 2014 --> Jun 2014
- levetiracetam / Generic mfg.
Enrollment open: LEV-AD: Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability (clinicaltrials.gov) - Jun 13, 2014
P2, N=36, Recruiting, Sponsor: University of California, San Francisco
Initiation date: Feb 2014 --> Jun 2014 Not yet recruiting --> Recruiting
- lorazepam / Generic mfg., levetiracetam / Generic mfg., midazolam hydrochloride / Generic mfg.
Enrollment open: TELSTAR: Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resuscitation (clinicaltrials.gov) - May 27, 2014
P=N/A, N=172, Recruiting, Sponsor: University of Twente
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | levetiracetam / Generic mfg.
Trial primary completion date: An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures (clinicaltrials.gov) - May 4, 2014
P3, N=44, Active, not recruiting, Sponsor: UCB, Inc.
Not yet recruiting --> Recruiting Trial primary completion date: Oct 2015 --> Jun 2016
- levetiracetam / Generic mfg.
Trial completion date: An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures (clinicaltrials.gov) - May 4, 2014
P3, N=44, Active, not recruiting, Sponsor: UCB, Inc.
Trial primary completion date: Oct 2015 --> Jun 2016 Trial completion date: Oct 2015 --> Jun 2016
- | levetiracetam / Generic mfg., oxcarbazepine / Generic mfg.
Enrollment open: Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE) (clinicaltrials.gov) - Apr 29, 2014
P3, N=300, Recruiting, Sponsor: Emory University
Trial completion date: Oct 2015 --> Jun 2016 Not yet recruiting --> Recruiting
- levetiracetam / Generic mfg., topiramate / Generic mfg.
Enrollment closed: Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures (clinicaltrials.gov) - Apr 27, 2014
P4, N=340, Active, not recruiting, Sponsor: UCB Korea Co. Ltd.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- levetiracetam / Generic mfg.
Enrollment change: Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention (clinicaltrials.gov) - Mar 6, 2014
P4, N=52, Completed, Sponsor: University of Cincinnati
Recruiting --> Active, not recruiting N=104 --> 52
- levetiracetam / Generic mfg.
Trial completion: Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention (clinicaltrials.gov) - Mar 6, 2014
P4, N=52, Completed, Sponsor: University of Cincinnati
N=104 --> 52 Recruiting --> Completed
- levetiracetam / Generic mfg.
Enrollment open: A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM (clinicaltrials.gov) - Jan 15, 2014
P2, N=30, Recruiting, Sponsor: University of Rochester
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| lacosamide / Generic mfg.
Enrollment change: VERVE: eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (clinicaltrials.gov) - Jan 13, 2014
P3, N=120, Completed, Sponsor: UCB, Inc.
Not yet recruiting --> Recruiting N=300 --> 120
- ||||||| lacosamide / Generic mfg.
Trial completion: VERVE: eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (clinicaltrials.gov) - Jan 13, 2014
P3, N=120, Completed, Sponsor: UCB, Inc.
N=300 --> 120 Active, not recruiting --> Completed
- | levetiracetam / Generic mfg.
Enrollment closed: An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures (clinicaltrials.gov) - Jan 9, 2014
P3, N=44, Active, not recruiting, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | levetiracetam / Generic mfg., carbamazepine / Generic mfg.
New P4 trial, Surgery: TTS (Time To Stop) Trial (EUDRACT) - Dec 29, 2013
P4, N=180, Ongoing, Sponsor: University Medical Center Utrecht
- lacosamide / Generic mfg.
Trial termination: VICTOR: Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide (clinicaltrials.gov) - Dec 9, 2013
P3, N=11, Terminated, Sponsor: UCB, Inc.
Recruiting --> Active, not recruiting Recruiting --> Terminated; Slow progress despite recruitment boosting efforts e.g., expert advice obtained from leading study center Investigators; decision thus made to terminate.
- lacosamide / Generic mfg.
Enrollment change: VICTOR: Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide (clinicaltrials.gov) - Dec 9, 2013
P3, N=11, Terminated, Sponsor: UCB, Inc.
Recruiting --> Terminated; Slow progress despite recruitment boosting efforts e.g., expert advice obtained from leading study center Investigators; decision thus made to terminate. N=28 --> 11
- Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
Enrollment change: Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders (clinicaltrials.gov) - Dec 9, 2013
P2, N=50, Recruiting, Sponsor: Sidney Kimmel Comprehensive Cancer Center
N=28 --> 11 N=25 --> 50
- levetiracetam / Generic mfg.
New P2 trial: LEV-AD: Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability (clinicaltrials.gov) - Dec 4, 2013
P2, N=36, Not yet recruiting, Sponsor: University of California, San Francisco
- || brivaracetam / Generic mfg.
Trial completion, Adverse events: Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) (clinicaltrials.gov) - Nov 27, 2013
P3, N=29, Completed, Sponsor: UCB Pharma SA
N=25 --> 50 Recruiting --> Completed
- ||| levetiracetam / Generic mfg.
Trial completion: Observational Study in Infants Who Are Prescribed Treatment With Keppra (clinicaltrials.gov) - Nov 24, 2013
P=N/A, N=101, Completed, Sponsor: UCB, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- zonisamide / Generic mfg., levetiracetam / Generic mfg., topiramate / Generic mfg.
Enrollment closed: Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism (clinicaltrials.gov) - Nov 13, 2013
P2, N=160, Active, not recruiting, Sponsor: Boston Medical Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- levetiracetam / Generic mfg.
New P2 trial: A Safety and Feasibility Study of Enteral LVT vs. Standard of Care for Seizure Control in Pediatric CM (clinicaltrials.gov) - Nov 11, 2013
P2, N=30, Recruiting, Sponsor: University of Rochester
- ||||||| levetiracetam / Generic mfg.
Trial completion: An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures (clinicaltrials.gov) - Oct 29, 2013
P3, N=73, Completed, Sponsor: UCB, Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | levetiracetam / Generic mfg.
New P4 trial: Seizure Prophylaxis in Aneurysm Repair (clinicaltrials.gov) - Oct 27, 2013
P4, N=266, Recruiting, Sponsor: Indiana University
- levetiracetam / Generic mfg.
Enrollment open: Seizure Prophylaxis in Aneurysm Repair (clinicaltrials.gov) - Oct 27, 2013
P4, N=266, Recruiting, Sponsor: Indiana University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- || levetiracetam / Generic mfg., fosphenytoin / Generic mfg.
New P3 trial, HEOR: ESETT: Established Status Epilepticus Treatment Trial (clinicaltrials.gov) - Oct 8, 2013
P3, N=795, Not yet recruiting, Sponsor: University of Virginia
- |||||||||| levetiracetam / Generic mfg., carbamazepine / Generic mfg.
New P3 trial, Monotherapy: Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures (clinicaltrials.gov) - Sep 29, 2013
P3, N=436, Recruiting, Sponsor: UCB Pharma SA
- ||||| levetiracetam / Generic mfg.
Enrollment closed: A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures) (clinicaltrials.gov) - Sep 15, 2013
P3, N=276, Active, not recruiting, Sponsor: UCB Japan Co. Ltd.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- levetiracetam / Generic mfg.
New P4 trial: SPLASH - Pilot: Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study (clinicaltrials.gov) - Sep 3, 2013
P4, N=36, Not yet recruiting, Sponsor: Vanderbilt University
- levetiracetam / Generic mfg., oxcarbazepine / Generic mfg.
Enrollment closed, Monotherapy: Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy (clinicaltrials.gov) - Aug 4, 2013
P4, N=353, Active, not recruiting, Sponsor: UCB Korea Co. Ltd.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | clonazepam / Generic mfg., levetiracetam / Generic mfg.
Enrollment change: SAMU-KEPPRA: Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus (clinicaltrials.gov) - Aug 1, 2013
P3, N=191, Active, not recruiting, Sponsor: Assistance Publique - H
Recruiting --> Active, not recruiting N=340 --> 191
- | clonazepam / Generic mfg., levetiracetam / Generic mfg.
Enrollment closed: SAMU-KEPPRA: Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus (clinicaltrials.gov) - Aug 1, 2013
P3, N=191, Active, not recruiting, Sponsor: Assistance Publique - H
N=340 --> 191 Recruiting --> Active, not recruiting
- || levetiracetam / Generic mfg.
Trial completion: A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures (clinicaltrials.gov) - Jul 29, 2013
P3, N=13, Completed, Sponsor: UCB, Inc.
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||| levetiracetam / Generic mfg.
Enrollment closed: UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra (clinicaltrials.gov) - Jul 18, 2013
P4, N=516, Active, not recruiting, Sponsor: UCB, Inc.
Recruiting --> Completed Recruiting --> Active, not recruiting
- levetiracetam / Generic mfg.
Enrollment change: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria (clinicaltrials.gov) - Jul 15, 2013
P1/2, N=7, Completed, Sponsor: Michigan State University
Recruiting --> Active, not recruiting N=30 --> 7
- levetiracetam / Generic mfg.
Trial completion: Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria (clinicaltrials.gov) - Jul 15, 2013
P1/2, N=7, Completed, Sponsor: Michigan State University
N=30 --> 7 Recruiting --> Completed
- || levetiracetam / Generic mfg., oxcarbazepine / Generic mfg.
New P3 trial: Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE) (clinicaltrials.gov) - Jul 1, 2013
P3, N=300, Recruiting, Sponsor: Emory University
- humanised dinutuximab (Hu14.18K322A) / Essential Pharma
Enrollment change, Metastases: Therapy for Children With Advanced Stage Neuroblastoma (clinicaltrials.gov) - Jun 3, 2013
P2, N=42, Recruiting, Sponsor: St. Jude Children's Research Hospital
Recruiting --> Completed N=110 --> 42
- humanised dinutuximab (Hu14.18K322A) / Essential Pharma
Enrollment open, Metastases: Therapy for Children With Advanced Stage Neuroblastoma (clinicaltrials.gov) - Jun 3, 2013
P2, N=42, Recruiting, Sponsor: St. Jude Children's Research Hospital
N=110 --> 42 Not yet recruiting --> Recruiting
- phenytoin / Generic mfg., levetiracetam / Generic mfg., fosphenytoin / Generic mfg.
Clinical: Antiepileptic Drugs and Vascular Risk Markers (clinicaltrials.gov) - May 20, 2013
P=N/A, N=40, Terminated, Sponsor: Thomas Jefferson University
Not yet recruiting --> Recruiting Recruiting --> Terminated; study no longer consistent with current clinical practice
- | phenytoin / Generic mfg., levetiracetam / Generic mfg., fosphenytoin / Generic mfg.
Trial termination: Antiepileptic Drugs and Vascular Risk Markers (clinicaltrials.gov) - May 20, 2013
P=N/A, N=40, Terminated, Sponsor: Thomas Jefferson University
Recruiting --> Terminated; study no longer consistent with current clinical practice N=200 --> 40 | Recruiting --> Terminated; study no longer consistent with current clinical practice
- pregabalin / Generic mfg., levetiracetam / Generic mfg.
Trial completion, Monotherapy: Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors (clinicaltrials.gov) - May 20, 2013
P2, N=52, Completed, Sponsor: Dr Andrea Rossetti
N=200 --> 40 | Recruiting --> Terminated; study no longer consistent with current clinical practice Active, not recruiting --> Completed
- humanised dinutuximab (Hu14.18K322A) / Essential Pharma
New P2 trial, Metastases: Therapy for Children With Advanced Stage Neuroblastoma (clinicaltrials.gov) - May 16, 2013
P2, N=42, Recruiting, Sponsor: St. Jude Children's Research Hospital